Similar articles

• Questions about anastrozole for early breast cancer.

  Thornton H. Thornton H. Lancet. 2002 Dec 7;360(9348):1890; author reply 1890-1. doi: 10.1016/S0140-6736(02)11759-4. Lancet. 2002. PMID: 12480405 No abstract available.
• Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.

  Hortobagyi GN, Buzdar AU. Hortobagyi GN, et al. Cancer Invest. 1998;16(6):385-90. doi: 10.3109/07357909809115778. Cancer Invest. 1998. PMID: 9679529 Review. No abstract available.
• [In Europe Anastrozole approved for first-line treatment of advanced breast cancer in postmenopausal patients].

  [No authors listed] [No authors listed] Tumori. 2000 May-Jun;86(3):A3. Tumori. 2000. PMID: 10939612 Italian. No abstract available.
• Adjuvant use of anastrozole in breast cancer.

  Cuzick J, Buzdar A, Baum M, Bianco R, Coleman R, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, MacKey J, Sainsbury R, Tobias J. Cuzick J, et al. J Clin Oncol. 2004 Apr 15;22(8):1524-6; author reply 1526-7. doi: 10.1200/JCO.2004.99.165. J Clin Oncol. 2004. PMID: 15084628 No abstract available.
• Anastrozole. An effective, second-line hormonal treatment for advanced breast cancer.

  Camp-Sorrell D. Camp-Sorrell D. Cancer Pract. 1997 Nov-Dec;5(6):391-3. Cancer Pract. 1997. PMID: 9397709 Review.